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The ratio (R) of zwitterions to neutral molecule was deter-
mined for the derivatives of 1-carboxymethylimidazole. 1-Carbo-
xymethylimidazole (I) and its 2-methyl derivate (III) were found 
to be entirely in the form of zwitterion. Of the two 1-carboxy-
methyl-2-methyl-nitroimidazoles (V and VII) the 4-nitroisomer (V) 
possesses no zwitterionic structure, but the 5-nitroisomer (VII) was 
found to be about 65Q/o in the zwitterionic form. The results obta-
ined are discussed in view of the significant analgetic and sedative 
effect observed with tlie compounds having a zwitterionic structure. 
4-(5)-Carboxymethylimidazole, or imidazole acetic acid (IMA) exhibits pro-
nounced pharmacological activities1- 3• Recently, its analgetic and sedative acti-
vity was interpreted as a consequence of the fact that its molecular structure 
contains the carboxylic group bonded by an intramolecular hydrogen bond 
to the N3 atom in the ring4• Following the mentioned postulation it could be 
proposed that derivatives of 1-carboxymethylimidazole have a neutral chelated 
form. 
However, knowing the high basicity of the imidazole ring (pKa = 6.95; 
6.895) and its inductive acid strengthening (electron-attracting) effect on the 
a-carboxylic group we have assumed that the zwitterion structure in the 
solution of IMA could be of greater importance than the unionized, chelated 
form. This assumption is based on an earlier observation6 that the imidazole-
-4(5)-carboxylic acid is about 980/o in a zwitterionic form (R = 57). 
One of the preliminary tests for the qualitative assessment of the structure 
of the zwitterion in aromatic amino-carboxylic acids7 and pyridine carboxylic 
acids8 is the hypsochromic shift of the K-band in the UV spectrum of carbo-
xylic group on addition of alkali. However, UV spectra of the compounds I, 
II, V and VII remained unchanged at various pH's. This is probably caused by 
an insulation effect of the CH2 group, which hinders conjugative interaction. 
Only a weak (E"" 60) R-band of a carboxylic group at 204-210 nm has been 
observed, which was regularly superimposed by a B-band of the imidazole 
ring9. The K-band of the nitroimidazole chromophore at 300-320 nm10 remai-
ned unchanged. 
* Taken in part from the Thesis of V. SunjiC, presented to the University of 
Zagreb, 1968, in partial fulfilment of the requirements for the degree of Doctor of 
Chemistry (Ph. D.). 
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Therefore, we have measured pKa values and estimated the ratio (R) of 
zwitterions to neutral molecule for the compounds I, III, V, and VII (Table I). 
The R values were calculated according to Ebert's equation7•11 ; R = antilog 
(pK0~1e - pKz) -1, where pK0~Ie is pK" of the corresponding m ethyl ester, 
and pKz is the lower pK" of the zwitterion. 
TABLE I 
pKa and R values of some derivatives of 1-carboxymethylimidazole" 
No. Compound pK'a I pK"a lpK' ''a I R Analgetic activity" 
I 1-Carboxymethylimidazole 2.66 6.64 28.089 ++ 
II 1-Carbomethoxymethy limidazole 7.12 




-4-nitroimidazole 0.20 1.94 
VI 1-Carbomethoxymethy 1-2-methy 1-
-4-nitromidazole 0.44 
VII 1-Carboxymethyl-2-methyl-
-5-nitroimidazole 2.06 2.40 1.9 ± VIII 1-Carbomethoxymethyl-2-methyl-
-5-nitroimidazole 2.52 
a The values pK'0 , pK"a etc., are given, by convention (ref. 7) , in order of increasing PKa. 
" Measured by the hot plate method (ref. 12) at doses 30-50 m g/kg. Data in reference to codeine phosphate as a standard; + means effect prolonging response time of animal 50' /o above that of standard; ± 100/o above that of standard; - , no observable effect. 
The compounds I and III are to a high degree in the zwitterionic form, 
and accordingly we assume that the carboxylic group in IMA could not be 
chelated as it was previously stated4 • The assignment of the pKa to a given 
basic or acidic group in the compounds V and VII have been performed accord-
ing to the data10 obtained earlier for the pK" values of a basic group in the 
I-substituted nitroimidazoles. It can be concluded that the compound V is not 
a zwitterion but an amphoteric substance because pKa value of its carboxylic 
group is numerically higher than that of the basic group7 • 
Compound VII proved to be ca. 65°/o in the zwitterionic form. 
Our pharmacological tests revealed that derivatives of 1-carboxymethyl-
imidazole possesses high pharmacological activity (analgetic, hypnotic and mu-
scular-relaxant). Compounds I and II exhibited pronounced analgetic activity, 
and the same activity has been observed with compound VII. Compound V, 
which has no zwitterionic structure, proved to be analgetically inactive. These; 
qualitative data suggest that there could be some correlation between zwit-
terionic structure and analgetic activity of these compounds. 
EXPERIMENTAL 
All melting points are determined on Boetius-Mikroheiztisch apparatus, F. Kilst-
ner/Dresden and are uncorrected. UV spectra were run on the Perkin-Elmer UV 129 Spectrophotometer. Potentiometric titrations were performed at 25 °C in 0.025 M 
water solutions deaerated with nitrogen before and during titration. Compounds VI 
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and VIII were titrated in 0.01 M solutions because of their lower solubility. The 
equivalency point was determined from the slope of the titration curve. pH measu-
rements were performed using glass and standard calomel (SCE) electrodes. Potassium 
biphthalate buffer (pH = 4.00) and borate buffer (pH = 9.18) were used as standards. 
Compounds V and VII were prepared according to the procedure previously 
described13• Compounds I and VIII were prepared following the methods mentioned 
in ref. 14 and 15, respectively. 
Analgetic activity was evaluated by the standard hot plate method used also 
in our previous work16. 
1-Carbomethoxymethylimidazole (II) 
3.15 g. (0.025 mole) of the compound I were dissolved in 25 ml. of methanol 
saturated with dry HCL The solution was heated on the steam bath for 2 hrs. , 
cooled and neutralized with methanolic NaOH to pH 6. The solvent was evaporated 
in vacuo, the residue dissolved,in 30 ml. of water and extracted with EtAc(3X30 ml). 
The combined extracts were dried (Na2S04) and the solvent evaporated in vacuo. 
The oily residue was fractionated at 0.1 mmHg yielding 2.8 g. of (II) b. p. 126-132° 
C/0.1 mmHg. 
Pi crate was prepared, and recrystallized from methanol - m. p. 148-149 °C. 
Anal. C1sH9N 50 9 (321.23) calc'd.: C 41.13; H 2.83; N 22.80°/o 
found: C 40.96; H 2.70; N 21.670/o 
1-Carboxymethyl-2-methylimidazole (III) 
Compound III was prepared from 8.2 g. (0.1 mole) of 2-methylimidazole and 18.::l 
g. (0.15 mole) of ethyl a-chloroacetate in 28 g. (35 ml) of iso-butanol. The reaction 
mixture was refluxed for 4 hours, and after evaporation of the solvent the residue 
was hydrolized with 30 ml. of 4 N NaOH on a steam bath. Acidification afforded 
9. 1 g. (640/o) of crude III m. p. 314-320 °C. On recrystallization from water the 
substance melted at 322-324 °C with decomposition. 
Anal. C6HsN20 2 (140.13) calc'd.: C 51.43; H 5.76; N 20.00°/o 
found: C 51.14; H 5.56; N 19.790/o 
1-Car bomethoxymeth y l-2-meth y limidazole (IV) 
According to the procedure described for II, from 3.5 g. (0.025 mole) of 1-car-
boxymethyl-2-methylimidazole, 2.35 g. (60.80/o) of IV was obtained. The crude product 
was purified by fractionation; an oily substance was obtained, b. p. 134-140°C/0.08-
-0.1 mmHg. · 
Anal. C7H1oN202 (154.17) calc'd.: C 54.53; H 6.54; N 18.170/o 
found: C 54.45; H 6.87; N 18.080/o 
1-Carbomethoxymeth y l-2-meth y l-4-nitroimidazole (VI) 
This ester was prepared from compound V13 in the same way as described for 
compound IL After evaporation of the solvent the residue was slurried in water and 
the crude VI was filtered off, m. p. 138-141 °C (yield 720/o). On recrystallization from 
water the substance, m . p. 141-142 °C was obtained. 
Anal. C7H9N304 (199.17) calc'd.: C 42.21 ; H 4.56; N 21.100/o 
found: C 41.97 ; H 4.32; N 21.330/o 
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IZVOD 
Struktura dipolnog iona u nekim 1-karboksimetilimidazolima njihova 
analgetska aktivnost 
V. Sunjic, F. Kajfez i P. Mildner 
Na osnovi mjerenja pK" odreden je omjer (R) dipolnog iona prema neutralnoj 
molekuli za cetiri derivata 1-karboksimetilimidazola. Nadeno je da SU 1-karboksime-
tilimidazol (I) i njegov 2-metil derivat (III) pretefoo u obliku dipolnog iona. Od dva 
izomerna 1-karboksimetil-2-metil-4 i 5-nitroirnidazola (V) i (VII) spoj V se ne nalazi 
u obliku dipolnog iona dok je spoj VII cca 650/o u tom obliku. Dobiveni rezultati 
su diskutirani u odnosu na ranije zapazeno analgetsko i sedativno djelovanje spojeva 
iz ove grupe. 
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